drugset / Trial / NCT06993337

Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Recurrent Aphthous Stomatitis

NCT06993337

Phase 2 Not yet recruiting 63 enrolled Cairo University
RandomizedParallel-groupTriple-blindTreatment

Summary

Bromelain, a natural product, exhibits anti-inflammatory, immunomodulatory, and wound-healing properties. However, its efficacy in treating oral mucosal ulcers remains unexplored. This study aims to evaluate the effect of bromelain as a safe alternate for management of RAS.

Timeline

Start
2025-06-15
Primary completion
2026-05-15
Completion
2026-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Bromelain Protein / enzyme biologic 35 % Topical
Subject Bromelain Protein / enzyme biologic 50 % Topical
Comparator Triamcinolone Acetonide Other / unclassified 0.1 % Topical

Indications